Poseida Therapeutics Inc (NASDAQ: PSTX) is 182.74% higher on its value in year-to-date trading and has touched a low of $1.87 and a high of $9.52 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The PSTX stock was last observed hovering at around $9.51 in the last trading session, with the day’s loss setting it -0.01%.
Currently trading at $9.50, the stock is 40.64% and 121.21% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.77 million and changing -0.11% at the moment leaves the stock 187.65% off its SMA200. PSTX registered 280.00% gain for a year compared to 6-month gain of 233.33%. The firm has a 50-day simple moving average (SMA 50) of $4.1574 and a 200-day simple moving average (SMA200) of $3.273725.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 157.45% loss in the last 1 month and extending the period to 3 months gives it a 209.45%, and is 1.82% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.12% over the week and 4.98% over the month.
Poseida Therapeutics Inc (PSTX) has around 330 employees, a market worth around $925.92M and $150.86M in sales. Profit margin for the company is -40.28%. Distance from 52-week low is 408.02% and -0.26% from its 52-week high. The company has generated returns on investments over the last 12 months (-37.08%).
The EPS is expected to grow by 48.40% this year
134.0 institutions hold shares in Poseida Therapeutics Inc (PSTX), with institutional investors hold 80.82% of the company’s shares. The shares outstanding are 97.41M, and float is at 67.38M with Short Float at 6.10%. Institutions hold 58.48% of the Float.
The top institutional shareholder in the company is FMR LLC with over 14.54 million shares valued at $42.47 million. The investor’s holdings represent 15.1465 of the PSTX Shares outstanding. As of 2024-06-30, the second largest holder is PENTWATER CAPITAL MANAGEMENT LP with 5.97 million shares valued at $17.45 million to account for 6.2227 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 4.91 million shares representing 5.1085 and valued at over $14.32 million, while BOXER CAPITAL, LLC holds 4.6605 of the shares totaling 4.47 million with a market value of $13.07 million.
Poseida Therapeutics Inc (PSTX) Insider Activity
The most recent transaction is an insider sale by Gergen Mark J, the company’s Executive Chairman. SEC filings show that Gergen Mark J sold 30,000 shares of the company’s common stock on Dec 10 ’24 at a price of $9.46 per share for a total of $0.28 million. Following the sale, the insider now owns 0.65 million shares.
Poseida Therapeutics Inc disclosed in a document filed with the SEC on Nov 26 ’24 that Gergen Mark J (Executive Chairman) sold a total of 30,000 shares of the company’s common stock. The trade occurred on Nov 26 ’24 and was made at $9.27 per share for $0.28 million. Following the transaction, the insider now directly holds 0.65 million shares of the PSTX stock.
Still, SEC filings show that on Nov 26 ’24, MARK GERGEN (Director) Proposed Sale 120,000 shares at an average price of $2.86 for $0.34 million. The insider now directly holds shares of Poseida Therapeutics Inc (PSTX).
